LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
TERN Terns Pharmaceuticals
- 5.770
- -0.110-1.87%
Close Dec 27 16:00 ET
- 5.780
- +0.010+0.17%
Post 20:01 ET
490.10MMarket Cap-4.89P/E (TTM)
5.950High5.700Low967.01KVolume5.840Open5.880Pre Close5.58MTurnover1.66%Turnover RatioLossP/E (Static)84.94MShares11.40052wk High1.34P/B335.32MFloat Cap4.32052wk Low--Dividend TTM58.11MShs Float28.360Historical High--Div YieldTTM4.25%Amplitude1.450Historical Low5.772Avg Price1Lot Size
About Terns Pharmaceuticals Company
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-? agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
Company Profile
SymbolTERN
Company NameTerns Pharmaceuticals
Listing DateFeb 5, 2021
Issue Price17.00
Founded2017
CEOMs. Amy Burroughs
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
Address1065 East Hillsdale Boulevard,Suite 100
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-525-5535
Websitehttp://www.ternspharma.com
Company Executives
- Name
- Position
- Salary
- Amy Burroughs
- Chief Executive Officer and Director
- --
- Dr. Mark J. Vignola, PhD
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 3.14M
- Melita Sun Jung
- Chief Business Officer
- --
- Elona Kogan
- Chief Legal Officer
- --
- Dr. Emil T. Kuriakose, M.D.
- President and Head, Research and Development
- --
- David Fellows
- Chairman of the Board
- 340.15K
- Dr. Erin Quirk, M.D.
- President and Head of Research and Development
- 4.67M
- Heather D. Turner
- Director
- --
- Dr. Radhika Tripuraneni, M.D.,M.P.H.
- Director
- 303.06K
- Jeffrey B. Kindler, Esq.
- Independent Director
- 304.99K
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- 298.99K
- Jill M. Quigley, Esq.
- Independent Director
- 306.14K
- Dr. Hongbo Lu, PhD
- Independent Director
- 299.99K